Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Sareum Holdings

    MCap

    GBP41m

    Last close

    GBP0.37

    ▲ 8.00 (27.59%)

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

    OpGen

    MCap

    USD58m

    Last close

    USD4.60

    ▲ 0.59 (14.60%)

  • Sectors

    Sectors

    View All Sectors
  • Megatrends

    Megatrends

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Cereno Scientific – executive interview

Cereno Scientific – executive interview

Cereno Scientific — 13 videos in collection

More on this equity

In this interview, we speak with Sten Sörensen, CEO of Cereno Scientific, about the strong momentum across the company’s clinical pipeline following its Q2 results. He emphasised the start of the global Phase IIb programme for lead asset CS1 in pulmonary arterial hypertension, with the first US site now activated and top-line data remaining on track for Q428, despite a modest shift in first-patient enrolment. Sten also discusses the encouraging long-term observations from the CS1 Expanded Access Programme and continued progress in partnering discussions. CS014 also remains firmly on track for its Q326 PK bridging readout, an important catalyst that could support the planned FDA Investigational New Drug application and a direct move into Phase IIb development in PH-ILD. He also provides an update on CS585 in antiphospholipid syndrome and outlines how Cereno is positioning its financing strategy to support the next phase of pipeline execution.

< Previous

You may also be interested in these:

Healthcare

Cereno Scientific – executive interview

Healthcare

Cereno Scientific – executive interview
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.